Rubel Chakravarty, Sudipta Chakraborty: A review of advances in the last decade on targeted cancer therapy using 177Lu: focusing on 177Lu produced by the direct neutron activation route. Am J Nucl Med Mol Imaging 2021;11(6):443-475. (Full text, PDF)
Euy Sung Moon, Sanjana Ballal, Madhav Prasad Yadav, Chandrasekhar Bal, Yentl Van Rymenant, Sarah Stephan, An Bracke, Pieter Van der Veken, Ingrid De Meester, Frank Roesch: Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time. Am J Nucl Med Mol Imaging 2021;11(6):476-491. (Full text, PDF)
Sandeep K Gupta, Natalie Rutherford, Xenia Dolja-Gore, Tahne Watson, Balakrishnan R Nair: Regional changes with global brain hypometabolism indicates a physiological triage phenomenon and can explain shared pathophysiological events in Alzheimer’s & small vessel diseases and delirium. Am J Nucl Med Mol Imaging 2021;11(6):492-506. (Full text, PDF)
Masakazu Kobayashi, Suguru Igarashi, Tatsuhiko Takahashi, Shunrou Fujiwara, Kohei Chida, Kazunori Terasaki, Yoshitaka Kubo, Kuniaki Ogasawara: Optimal timing for measuring cerebral blood flow after acetazolamide administration to detect preexisting cerebral hemodynamics and metabolism in patients with bilateral major cerebral artery steno-occlusive diseases: 15O positron emission tomography studies. Am J Nucl Med Mol Imaging 2021;11(6):507-518. (Full text, PDF)
Andrea O Fontana, Mary Gonzalez Melo, Gilles Allenbach, Costa Georgantas, Ruijia Wang, Olivier Braissant, Frederic Barbey, John O Prior, Diana Ballhausen, David Viertl: The use of 68Ga-EDTA PET allows detecting progressive decline of renal function in rats. Am J Nucl Med Mol Imaging 2021;11(6):519-528. (Full text, PDF)
Huating Kong, Minjun Li, Qin Xu, Huan Zhou, Feng Yu, Qisheng Wang: Implementation of level-2 biosafety for a macromolecular crystallography beamline at SSRF. Am J Nucl Med Mol Imaging 2021;11(6):529-536. (Full text, PDF)
Chunxia Qin, Yangmeihui Song, Weibo Cai, Xiaoli Lan: Dimeric FAPI with potential for tumor theranostics.: Dimeric FAPI with potential for tumor theranostics.. Am J Nucl Med Mol Imaging 2021;11(6):537-541. (Full text, PDF)
